02 May 2017 | News
The award honors MiMedx for the high level of member adoption of the EpiFix® dehydrated Human Amnion/Chorion Membrane (dHACM) allograft
MiMedx Group, Inc., the leading biopharmaceutical company developing and marketing regenerative biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of healthcare, has received the Innovative Technology Supplier of the Year Award from Vizient, Inc., the nation's largest member-driven health care improvement company in the country. The award recognizes MiMedx for its positive impact on patient care provided through Vizient members in 2016. The award was presented earlier this month at the 2017 Vizient Supplier Summit.
The award honors MiMedx for the high level of member adoption of the EpiFix® dehydrated Human Amnion/Chorion Membrane (dHACM) allograft, which received an Innovative Technology contract in May 2015. The contract was based on recommendations from experts at Vizient member hospitals that the MiMedx allograft offers unique and incremental benefit over other products available on the market today.
Vizient's diverse membership base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers, and represents more than $100 billion in annual aggregate purchasing volume.